Totalseq-D human heme oncology cocktail biolegend INC:1135351 [26-004804]

Ended Purchase Order Awarded

Contract number
75N98026P00452
Awardee
Awarding agency
Obligated
$16,488

Award facts

Contract value 100% obligated
$16,488.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
NIH Clinical Center National Institutes of Health, Department of Health and Human Services
NAICS code
325414 Biological Product (except Diagnostic) Manufacturing
PSC
6640 Laboratory Equipment And Supplies
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
San Diego, CA 92121, USA

Award details come from SAM.gov/FPDS.

About this award

The NIH Clinical Center awarded a purchase order to Biolegend, Inc. for $16,488.00 on May 7, 2026, for TOTALSEQ-D Human Heme Oncology Cocktail biomedical reagents. No small business set-aside was applied. Work is performed in San Diego, California. The order carries a firm fixed price and is scheduled for completion by September 30, 2026.

Quick answers

Who was awarded contract 75N98026P00452?

75N98026P00452 was awarded to Biolegend, Inc. by Office of Logisitics and Acquisition Operations (National Institutes of Health) on May 7, 2026.

How much is contract 75N98026P00452 worth?

The government has obligated $16,488 on 75N98026P00452.

Which agency awarded contract 75N98026P00452?

Office of Logisitics and Acquisition Operations (National Institutes of Health) awarded 75N98026P00452, with funding from NIH Clinical Center (National Institutes of Health).

Was contract 75N98026P00452 competed?

The extent of competition for 75N98026P00452 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award